Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes

CompletedOBSERVATIONAL
Enrollment

1,845

Participants

Timeline

Start Date

January 1, 2008

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Kidney Transplant Failure and Rejection
Interventions
DIAGNOSTIC_TEST

Anti-angiotensin II type 1 receptor antibody measurement

Anti-angiotensin II type 1 receptor antibodies are assessed using quantitative ELISA in stored serum samples obtained within the first year after transplantation

DIAGNOSTIC_TEST

Measurement of ENDAT expression level allograft

Endothelial-associated transcript expression level is assessed using microarray in stored kidney allograft biopsies obtained within the first year after transplantation

OTHER

Allograft survival

OTHER

Allograft rejection appearance

Trial Locations (2)

75010

Kidney Transplant Department, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France, Paris

75015

Kidney Transplant Department, Necker Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France, Paris

All Listed Sponsors
collaborator

Center for Cardiovascular Research Berlin

OTHER

lead

Paris Translational Research Center for Organ Transplantation

OTHER

NCT03466775 - Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes | Biotech Hunter | Biotech Hunter